Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal indomethacin plus vitamin C versus rectal indomethacin for prevention of post-ERCP pancreatitis
IRCT20121021011192N11Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of indomethacin and ascorbic acid in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Occurrence of pancreatitis. Started May 2021; status: completed.
02
Drugs
indomethacinascorbic acid
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on IRCT20121021011192N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121021011192N11.